These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Effectiveness and tolerance of tramadol in cancer pain. A comparative study with respect to buprenorphine]. Bono AV; Cuffari S Drugs; 1997; 53 Suppl 2():40-9. PubMed ID: 9190324 [TBL] [Abstract][Full Text] [Related]
5. Trends in Tramadol: Pharmacology, Metabolism, and Misuse. Miotto K; Cho AK; Khalil MA; Blanco K; Sasaki JD; Rawson R Anesth Analg; 2017 Jan; 124(1):44-51. PubMed ID: 27861439 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics, efficacy, and safety of analgesia with a focus on tramadol HCl. Gibson TP Am J Med; 1996 Jul; 101(1A):47S-53S. PubMed ID: 8764760 [TBL] [Abstract][Full Text] [Related]
7. Extended-release Tramadol (ULTRAM ER): a pharmacotherapeutic, pharmacokinetic, and pharmacodynamic focus on effectiveness and safety in patients with chronic/persistent pain. Barkin RL Am J Ther; 2008; 15(2):157-66. PubMed ID: 18356636 [TBL] [Abstract][Full Text] [Related]
8. Tramadol: a new centrally acting analgesic. Lewis KS; Han NH Am J Health Syst Pharm; 1997 Mar; 54(6):643-52. PubMed ID: 9075493 [TBL] [Abstract][Full Text] [Related]
9. Tramadol--the impact of its pharmacokinetic and pharmacodynamic properties on the clinical management of pain. Klotz U Arzneimittelforschung; 2003; 53(10):681-7. PubMed ID: 14650359 [TBL] [Abstract][Full Text] [Related]
10. "Weak" opioid analgesics. Codeine, dihydrocodeine and tramadol: no less risky than morphine. Prescrire Int; 2016 Feb; 25(168):45-50. PubMed ID: 27042732 [TBL] [Abstract][Full Text] [Related]
11. [Tramadol in acute pain]. Lehmann KA Drugs; 1997; 53 Suppl 2():25-33. PubMed ID: 9190322 [TBL] [Abstract][Full Text] [Related]
12. Unexceptional seizure potential of tramadol or its enantiomers or metabolites in mice. Raffa RB; Stone DJ J Pharmacol Exp Ther; 2008 May; 325(2):500-6. PubMed ID: 18292293 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic properties of tramadol IR and SR in elderly patients: a prospective, age-group-controlled study. Likar R; Wittels M; Molnar M; Kager I; Ziervogel G; Sittl R Clin Ther; 2006 Dec; 28(12):2022-39. PubMed ID: 17296459 [TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetics of tramadol in children]. Saudan S; Habre W Ann Fr Anesth Reanim; 2007 Jun; 26(6):560-3. PubMed ID: 17524604 [TBL] [Abstract][Full Text] [Related]
15. Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states. Lee CR; McTavish D; Sorkin EM Drugs; 1993 Aug; 46(2):313-40. PubMed ID: 7691519 [TBL] [Abstract][Full Text] [Related]
16. Effects of terbinafine and itraconazole on the pharmacokinetics of orally administered tramadol. Saarikoski T; Saari TI; Hagelberg NM; Backman JT; Neuvonen PJ; Scheinin M; Olkkola KT; Laine K Eur J Clin Pharmacol; 2015 Mar; 71(3):321-7. PubMed ID: 25560051 [TBL] [Abstract][Full Text] [Related]
18. Tramadol: a review of its use in perioperative pain. Scott LJ; Perry CM Drugs; 2000 Jul; 60(1):139-76. PubMed ID: 10929933 [TBL] [Abstract][Full Text] [Related]
19. Paroxetine, a cytochrome P450 2D6 inhibitor, diminishes the stereoselective O-demethylation and reduces the hypoalgesic effect of tramadol. Laugesen S; Enggaard TP; Pedersen RS; Sindrup SH; Brøsen K Clin Pharmacol Ther; 2005 Apr; 77(4):312-23. PubMed ID: 15903129 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of CYP2D6-mediated tramadol O-demethylation in methadone but not buprenorphine maintenance patients. Coller JK; Michalakas JR; James HM; Farquharson AL; Colvill J; White JM; Somogyi AA Br J Clin Pharmacol; 2012 Nov; 74(5):835-41. PubMed ID: 22369095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]